The long-term goal of this project is to understand the mechanism of age-related meibomian gland dysfunction (MGD) and evaporative Dry Eye. Recently we have shown that mouse and human meibomian glands undergo specific age-related changes including decreased acinar cell proliferation, acinar atrophy, and altered peroxisome proliferator-activated receptor gamma (PPARg) localization from cytoplasmic-vesicluar/nuclear in young to nuclear in old mice and humans. Since PPARg is a lipid sensitive, nuclear receptor implicated in regulating adipocyte and sebocyte differentiation and lipogenesis, our findings suggest that PPARg may be involved in modulating meibomian gland differentiation during aging. Based on these findings we propose that aging of the meibomian gland may result in down-regulation of PPARg leading to decreased meibocyte differentiation and lipid synthesis, gland atrophy, and a hyposecretory MGD. Currently, there is a MAJOR GAP in knowledge regarding the role of PPARg in meibomian gland function. To test this hypothesis we have develop novel imaging and cell culture systems to assess gland volume, lipid synthesis and their regulation by PPARg. Using non-linear optical (NLO) microscopy and array tomography we have volumetrically reconstructed the mouse meibomian gland and measured total, cellular and lipid volumes in young and old glands. Preliminary studies suggest that atrophy of aging meibomian glands involves a marked loss in the lipid volume suggesting decreased meibocyte differentiation. Additionally, we have used coherent anti-stokes raman spectroscopy (CARS) to identify the regional lipid profiles within the meibomian gland and have tentatively shown that there is an age-related change in the maturation of meibomian gland lipids moving from the acini into the duct. Furthermore, we have developed an SV40 immortalized mouse meibocyte cell line that synthesizes lipids and expresses PPARg. Using these novel tools we propose the following Specific Aims. (1). Establish the age-related changes in PPARg localization and associated gene expression patterns by quantifying the subcellular localization, post-translational modification and downstream response gene expression patterns in the mouse and human meibomian gland. (2) Determine the effects of aging on the meibomian gland by quantifying the volume and lipid synthesis using NLO microscopy and array tomography to volumetrically reconstruct the meibomian gland and CARS to assess regional changes in lipid components present in the acini, ductule and duct of the mouse and human meibomian gland. (3) Assess the effects of natural and synthetic PPARg ligands on lipid synthesis by quantifying the subcellular localization, post- translational modification and downstream response gene expression patterns in cultured mouse meibocytes. (4) Measure the effect of PPARg ligands on meibocyte differentiation in vivo by quantifying the changes in PPARg expression, meibocyte proliferation, gland volume and lipid synthesis in young and old mouse meibomian glands.
. Age-Related meibomian gland dysfunction (MGD) is a common eyelid disorder having a widespread prevalence of 39-50% in the US population and is a major cause of evaporative dry eye disease in the aging population. Our studies thus far suggest that age-related MGD in humans and mice involve altered peroxisome proliferator-activated receptor gamma (PPARg) localization. Since PPARg is known to regulate lipogenesis and sebocyte differentiation, understanding its role in age-related MGD may provide a mechanistic understanding of evaporative dry eye as well as suggest novel therapeutic strategies for treating human MGD.
|Parfitt, Geraint J; Brown, Donald J; Jester, James V (2016) Transcriptome analysis of aging mouse meibomian glands. Mol Vis 22:518-27|
|Jester, James V; Potma, Eric; Brown, Donald J (2016) PPARÎ³ Regulates Mouse Meibocyte Differentiation and Lipid Synthesis. Ocul Surf 14:484-494|
|Parfitt, Geraint J; Lewis, Phillip N; Young, Robert D et al. (2016) Renewal of the Holocrine Meibomian Glands by Label-Retaining, Unipotent Epithelial Progenitors. Stem Cell Reports 7:399-410|
|Parfitt, Geraint J; Kavianpour, Behdad; Wu, Karen L et al. (2015) Immunofluorescence Tomography of Mouse Ocular Surface Epithelial Stem Cells and Their Niche Microenvironment. Invest Ophthalmol Vis Sci 56:7338-44|
|Jester, James V; Parfitt, Geraint J; Brown, Donald J (2015) Meibomian gland dysfunction: hyperkeratinization or atrophy? BMC Ophthalmol 15 Suppl 1:156|
|Chernyavsky, Alex I; Galitovskiy, Valentin; Shchepotin, Igor B et al. (2014) The acetylcholine signaling network of corneal epithelium and its role in regulation of random and directional migration of corneal epithelial cells. Invest Ophthalmol Vis Sci 55:6921-33|
|Suhalim, Jeffrey L; Parfitt, Geraint J; Xie, Yilu et al. (2014) Effect of desiccating stress on mouse meibomian gland function. Ocul Surf 12:59-68|
|Parfitt, Geraint J; Xie, Yilu; Geyfman, Mikhail et al. (2013) Absence of ductal hyper-keratinization in mouse age-related meibomian gland dysfunction (ARMGD). Aging (Albany NY) 5:825-34|
|Parfitt, Geraint J; Xie, Yilu; Reid, Korey M et al. (2012) A novel immunofluorescent computed tomography (ICT) method to localise and quantify multiple antigens in large tissue volumes at high resolution. PLoS One 7:e53245|
|Jester, James V; Brown, Donald J (2012) Wakayama Symposium: Peroxisome proliferator-activated receptor-gamma (PPARÎ³) and meibomian gland dysfunction. Ocul Surf 10:224-9|
Showing the most recent 10 out of 12 publications